Synthesis of shape-controlled polymer nano / microstructures using initiated chemical vapor deposition (ICVD) polymerization in structured liquids
Patent Information
- Application Number
- PCT/US2023/066722
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-05-08
- Filing Date
- 2023-05-08
- Publication Date
- 2024-11-21
AI Technical Summary
Current synthesis approaches for polymer structures are laborious and insufficiently versatile, often resulting in spherical particles, and achieving non-spherical shapes requires a complete redesign of the synthesis procedure, limiting the diversity and programmability of polymer nano/microstructures.
The use of initiated chemical vapor deposition (iCVD) polymerization in nematic liquid crystals (LC) enables the synthesis of a wide variety of shape-controlled polymer particles, including nanospheres, hemispherical domes, microspheres, spheroids, and discs, by tuning synthesis conditions such as flow rates and LC alignment, with real-time monitoring using in-situ long focal range reflection-mode microscopy.
This method provides unprecedented versatility and control over polymer particle shapes, allowing for the formation of diverse morphologies using a single synthesis platform compatible with a large library of functional monomers, while maintaining the LC template's structural integrity throughout the polymerization process.
Smart Images

Figure 000001 
Figure 000002 
Figure 000003
Abstract
Description
SYNTHESIS OF SHAPE-CONTROLLED POLYMER NANO / MICROSTRUCTURES USING INITIATED CHEMICAL VAPOR DEPOSITION (iCVD) POLYMERIZATION IN STRUCTURED LIQUIDS CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority to U.S. Provisional Application No.63 / 364,342, filed on May 8, 2022, the entire contents of which are hereby incorporated by reference herein. GOVERNMENT LICENSE RIGHTS
[0002] This invention was made with government support under 90892 awarded by the Department of the Navy Science and Technology, and 140459, 2229092, and 88878 awarded by the National Science Foundation. The government has certain rights in the invention. BACKGROUND
[0003] The ability to synthesize functional polymer structures with programmable shapes is advantageous for a wide range of applications, such as particles for drug delivery with programmable pharmacokinetics, oriented fibers for efficient electrolytic capacitors and batteries, isoporous films for membrane separations, etc.
[0004] U.S. Patent No.10,907,038 discloses methods for fabricating nanowires / nanofibers arrays via chemical vapor deposition polymerization of paracyclophanes or substituted paracyclophanes. Temperatures of at least 500° C are used to pyrolyze the precursors to form paracyclophane reactive monomers. The polymerization is step polymerization, which is performed in a polymerization reactor having a temperature of about 75° C –150° C and results in anisotropic polymerization of the paracyclophane reactive monomers to form the nanowires / nanofibers arrays.
[0005] While nanowire / nanofiber arrays have been fabricated, current synthesis approaches for polymer structures / particles remain laborious and insufficiently versatile.
[0006] Thus, a need remains for improved polymer structures, and for methods of making the same. 1SUMMARY OF THE INVENTION
[0007] Briefly, embodiments of the present invention provide improved polymer structures, and methods of making the same.
[0008] Current synthesis approaches for polymer particles are laborious and insufficiently versatile. For example, driven by surface tension effects, polymer nano / microparticles are predominantly spheres and the obtainment of non-spherical shapes often requires complete redesign of the synthesis procedure. Using a novel synthesis platform, where initiated chemical vapor deposition (iCVD) polymerization of divinylbenzene was performed in nematic liquid crystals (LC), a host of shape-controlled polymer particles ranging from nanospheres, hemispherical microdomes, randomly oriented or directed microgel, microspheres, spheroids, and microdiscs were obtained simply by tuning the synthesis conditions such as the flow rates of monomer and LC alignment. The unprecedented versatility and shape control was enabled by a deep understanding of the mechanism of reaction and transport in the dynamic LC achieved using a novel assembly of in-situ long focal range reflection-mode microscopy with the reactors. The in-situ imaging capability bridged a critical knowledge gap in liquid templated polymerization, the mechanism of which remained elusive partially due to the depleting reactant concentrations and changing LC alignments over the course of polymerization. Applying the iCVD polymerization technique to LC enabled continuous and controlled vapor phase delivery to achieve concentrations below the structure-disrupting threshold of LC templates throughout the process with real-time monitoring. Nematic LC medium being a poorer solvent led to the formation of nanospheres in bulk in contrast to microspheres obtained in conventional isotropic solvents used for precipitation polymerization (e.g., chain-growth polymerization) of divinylbenzene. These precipitating nanospheres constituted as the building blocks aggregating into shaped-microgel clusters on the LC-solid interface. Guided by the LC template near the interface, hemispherical domes in homeotropically aligned LC and randomly oriented or directional clusters in two different hybrid templates were obtained. Further obtained were microspheres, spheroids, and unique disc-shaped particles desolvating from the microgel clusters formed at the LC-solid interface at later stages. Additionally, iCVD polymerization was observed to cause lowering of LC-surface anchoring energy over the course of reaction. This is the firsttime synthesis of such a wide variety of tunable shaped polymer particles has been demonstrated using a single synthesis platform compatible with a large library of functional monomers.
[0009] In one aspect, the invention provides a method of synthesizing polymer particles, said method comprising, in a reactor having a substrate with a liquid crystal (LC) disposed thereon: introducing vapor-phase reagents into the reactor; contacting the reagents with the LC, dissolving the reagents in the LC, or a combination thereof; introducing polymerization initiator into the reactor; and forming polymer particles via chain-growth polymerization.
[0010] In a second aspect, the invention provides a polymer particle prepared according to the first aspect of the invention.
[0011] These and other objects, features, and advantages of this invention will become apparent from the following detailed description of the various aspects of the invention taken in conjunction with the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[0012] FIG.1 shows (A) Schema of the iCVD synthesis apparatus, (B) two examples of the optical output monitored in real time using the custom in-situ long-focal range microscope and, (C) cross-section schema of the iCVD reactor chamber, where initiator breaks down to form free radicals. The free radicals enter the LC and start polymerization upon reacting with dissolved monomers, giving rise to the polymeric particles with varying shapes. (D) Mechanistic insights into the iCVD in LC process. Bulk nematic LC acts as a marginal solvent resulting in continuous precipitation of pDVB as nanospheres. The nanospheres form via the 5-step precipitation polymerization mechanism: (i) dissolution of monomer in the LC, (ii) formation of oligomers, (iii) particle nucleation via coagulation of oligomers, (iv) growth into colloidally stable seed and, (v) phase-separation into nanosphere. The LC-substrate interface facilitates asecond round of the 5-step growth, where the precipitated nanospheres at the interface (analogous to the oligomeric building blocks in bulk) form particle nuclei, LC-directed microgel clusters, and then phase-separated micron-sized shaped particles.
[0013] FIG.2 shows in-situ characterization during iCVD in LC enabled by our custom long focal range microscope. (A) Determination of monomer threshold concentration by observing LC phase transition from nematic to isotropic phase, (B) In-situ observation of emergence of phase separated polymer structures during iCVD polymerization in LC and, (C) Real-time monitoring of LC alignment captures lowering of LC anchoring energy during iCVD polymerization.
[0014] FIG.3 shows an investigation of the mechanism of LC anchoring transition. Schematic of the experimental setup (A-C), their corresponding orthoscopic and conoscopic (insets) cross polarized optical micrographs (D-F) and the corresponding schematics of LC molecular orientation in each system (G-I).
[0015] FIG.4 shows the progression of morphology of pDVB particles from nanospheres to microgel clusters to micron-sized spheres, spheroids, and discs in LC on glass coated by polyimide (PI). (A-D) Ex-situ bright field optical micrographs showing the formation of shaped polymer structures (dark clusters) in LC. (E-H) Representative SEM images revealing the detailed shapes of the polymer particles formed at the LC-substrate interface. A subpopulation of the precipitated nanospheres is highlighted in orange (false colored) in each SEM image to illustrate their continuous precipitation. A small number of microparticles emerging from a microgel cluster are highlighted in blue (false colored) in G to illustrate microgel cluster phase separating into discrete particles. (I-M) Laser confocal Raman microscopy of E7, DVB monomer, and the various polymer morphologies. Microscopy images on the left in each panel show the polymer structure on which the spectrum to the right was taken; the white box indicates the excitation area. The percent represents vinyl bonds left unreacted in each case (normalized by vinyl bonds in DVB monomer) as derived from the Raman spectra. (N) Particle size distribution of the nanospheres and microparticles formed by the iCVD-in-LC process.
[0016] FIG 5. Shows time progression of shaped polymeric structures from real-time monitoring of iCVD polymerization for 60 mins Snapshots taken from in-situ observation inbright-field mode (see Movie S4 for video) captures the progression of reaction from homogenous reactant mixture at the start (A), to observation of nanospheres at 25 minutes (B) and, formation of elongated microgel clusters from nanospheres at 50 minutes (C).
[0017] FIG.6 shows polymeric shapes obtained after removal of LC using CPD coincides with the observed shapes after ethanol washing. Representative SEM images captures the microgel clusters formed after 65 minutes of polymerization (A) and, micron-sized spheroids formed after 120 and 180 minutes of polymerization at LC-substrate interface (B-C).
[0018] FIG.7 shows the molecular structure for constituents of E7 LC mixture.
[0019] FIG.8 shows the Size distribution of nanospheres and microgels obtained at the end of 65 minutes of polymerization using DLS.
[0020] FIG.9 shows film formation at LC-vapor interface. Partial film coverage was observed for polymerization till 65 minutes (A), and porous film formation was observed for longer reaction times, i.e., 120 minutes (B) and 180 minutes (C). Note that, to maintain the film structure formed on LC-vapor interface at top for SEM imaging, in these experiments LC was removed by vacuum drying for 1 day at 75oC.
[0021] FIG.10 shows the role of LC alignment in shaping and directing microgel clusters. (A-C) LC alignment on the three solid substrates used in this work: glass functionalized by octadecyltrichlorosilane (OTS), bare glass, and glass coated by PI and then rubbed. In each panel, the representative cross-polarized micrographs are accompanied by the corresponding schematics showing the orientation of E7 in the x-z plane (i.e., cross-section) and x-y plane (i.e., top-down at the LC-substrate interface), respectively. The red arrow corresponds to the rubbing direction on the PI substrate. (D-F) SEM images of the polymeric structures formed in each LC template: OTS-treated glass, bare glass, and glass covered by rubbed PI led to dome-shaped, randomly oriented, and directional microgel clusters, respectively. (G-I) The frequency of appearance of microgel clusters with specific aspect ratios, revealing the statistics of shape anisotropy on the three substrates. OTS-treated glass led to circular or near-circular shape due to the homeotropic alignment of E7; bare glass and glass covered by rubbed PI led to elongated microgels due to their hybrid alignment of E7, as shown in the x-z plane orientation in A-C. (J-L) Bright field optical micrographs obtained for the three substrates, where polymeric clusters were captured as dark clusters. The red arrow corresponds to the rubbing direction of the PI substrate. (M-O) Directionality analysis of the polymeric clusters in J-L, highlighting the aligned polymeric structures on rubbed PI (O), oriented along the presumed direction of rubbing, in contrast to the absence of directionality on OTS-treated glass and bare glass (M, N).
[0022] FIG.11 shows the morphology progression of the pDVB particles from nanospheres to microgel clusters to micron-sized spheres, spheroids, and discs over time during the iCVD in LC process on glass substrate. (A-D) Ex-situ bright field optical micrographs capturing the formation of polymer structures (dark clusters) over one complete grid of LC medium, (E-H) Representative SEM images capturing the detailed shapes of the polymer particles formed at the LC-substrate interface. Presence of nanospheres at all times illustrate their continuous precipitation.
[0023] FIG.12 shows the morphology progression of the pDVB particles from nanospheres to microgel clusters (dome-shaped) over time during the iCVD in LC process on OTS substrate. (A-D) Ex-situ bright field optical micrographs capturing the formation of polymer structures (dark clusters) over one complete grid of LC medium, (E-H) Representative SEM images capturing the detailed shapes of the polymer particles formed at the LC-substrate interface. Presence of nanospheres at all times illustrate their continuous precipitation. Shape progression for polymerization on OTS substrate was observed to be slower than the other two substrates, with formation of dome-shaped microgels starting after 90 minutes in the reaction and no observation of the second phase separation at LC-substrate interface even after 180 minutes.
[0024] FIG.13 shows properties of microgel clusters formed in LC on OTS, glass, and rubbed-PI substrates. Representative Raman microscopy images, corresponding SEM images, Raman spectra and % vinyl bonds left unreacted characterized for microgel clusters formed in OTS (A-C), glass (D-F) and rubbed-PI (G-I) LC templates, respectively. The difference in % unreacted vinyl bonds are statistically not significant between OTS and glass (with p = 0.129), not significant between glass and rubbed-PI (with p = 0.094) but is significant between OTS and rubbed-PI (with p = 0.0066). The observed difference is likely due to difference in diffusion coefficients in x-y plane (owing to different mesogenic alignments) which results in differentrates of aggregation of nanospheres (slower in OTS) than heterogenous polymerization, resulting in higher % unreacted vinyl bonds in OTS. (J) SEM images indicative of mechanism of simultaneous aggregation of precipitated nanospheres and heterogenous polymerization.
[0025] FIG.14 shows properties of microparticles formed in LC on glass and rubbed-PI substrates. Representative Raman microscopy images, corresponding SEM images, Raman spectra and % vinyl bonds left unreacted characterized for particles formed in glass (A-C) and, rubbed-PI (D-F) LC templates, respectively. The % unreacted vinyl bonds are not statistically different (with p = 0.295). (G) Particle size distribution for particles formed after 120 and 180 minutes of polymerization in LC on glass and rubbed-PI functionalized glass, respectively.
[0026] FIG.15 shows bulk alignment of microgels on rubbed PI-functionalized substrates. Bright-field optical micrographs of several grids captured over a length scale of 3.05 mm (A-D) and corresponding directionality histograms (E-H) of the polymeric clusters highlight the presumed direction of rubbing on the substrate.
[0027] FIG.16 shows, in (A), synthesis of shaped polymeric particles using iCVD in LC. SEM images of the particle shapes (top & side views) that show the detailed polymer morphology at different growth stages. Although different samples were examined in the top- versus side-view SEM images, they were synthesized under identical conditions, reaction time, and LC template. Nanoparticles are synthesized by performing reaction for 30 minutes in both homeotropic and hybrid LCs; hemispherical domes and elongated clusters are formed by performing reaction for 65 minutes in homeotropic and hybrid LC respectively; microparticles with different shapes (spheres, spheroids, discs) are formed by performing reaction between 120- 180 minutes in hybrid LC. (B) Encapsulation and release of E7 molecules by the shape- controlled particles. SEM image (left) of the corresponding particle for which the Raman spectra (right) were collected and, microscopy image (middle) and the Raman spectra (right) obtained before and after release of E7, respectively.
[0028] FIG.17 shows the percentage unreacted vinyl bonds present in microparticles before and after LC release for particles formed over glass (p = 0.882) and rubbed-PI (p = 0.851).DETAILED DESCRIPTION
[0029] In the following and attached description, reference is made to the accompanying drawings and text that form a part hereof, and in which is shown by way of illustration specific embodiments which may be practiced. These embodiments are described in detail to enable those skilled in the art to practice the invention, and it is to be understood that other embodiments may be utilized and that structural, logical and electrical changes may be made without departing from the scope of the present invention. The following and attached description of example embodiments is, therefore, not to be taken in a limited sense, and the scope of the present invention is defined by the appended claims.
[0030] While certain aspects of conventional technologies have been discussed to facilitate disclosure of the invention, Applicant in no way disclaims these technical aspects, and it is contemplated that the claimed invention may encompass one or more of the conventional technical aspects discussed herein.
[0031] In this application, where a document, act or item of knowledge is referred to or discussed, this reference or discussion is not an admission that the document, act or item of knowledge or any combination thereof was, at the priority date, publicly available, known to the public, part of common general knowledge, or otherwise constitutes prior art under the applicable statutory provisions; or is known to be relevant to an attempt to solve any problem with which this specification is concerned.
[0032] The terminology used herein is standard terminology in the art and is used as understood by persons of skill in the art.
[0033] In one aspect, the invention provides a method of synthesizing polymer particles, said method comprising, in a reactor having a substrate with a liquid crystal (LC) disposed thereon: introducing vapor-phase reagents into the reactor; contacting the reagents with the LC, dissolving the reagents in the LC, or a combination thereof;introducing polymerization initiator into the reactor; and forming polymer particles via chain-growth polymerization.
[0034] The polymerization carried out in accordance with the first aspect of the invention is chain-growth polymerization. Chain growth polymerization is a process in which polymers are formed from unsaturated monomers. Chain growth polymerization is also called addition polymerization because monomers are added to growing ends of polymer chains, at chain end or a branching point. The monomers are attached to the chain in the active sites of the growing polymer chain. The growth of polymer chains occurs only at the ends. Chain combination commonly terminates chain growth. Chain growth polymerization can be distinguished from step growth polymerization (as utilized, e.g., in the methods of U.S.10,907,038), which is the formation of a polymer from bi-functional or multi-functional monomers and does not require unsaturated monomers. Step growth polymerization is also known as condensation polymerization. Unlike in chain growth polymerization, the polymer chains here are not formed at the beginning. First, dimers, trimers, and tetramers are formed. Then, these oligomers combine with each other forming long polymer chains. Such combinations commonly do not terminate chain growth. Therefore, the monomers are not attached to the ends of polymer chains as in chain growth polymerization.
[0035] In some embodiments, the vapor-phase reagents include one or more monomers. It is within the purview of a person skilled in the art to be able to select monomers that are amenable to use in the inventive method, and it is contemplated that all such monomers may be used.
[0036] In some embodiments, the one or more monomers comprise 2-hydroxyethyl methacrylate, divinylbenzene, 4-vinylpyridine, benzyl methacrylate, ethylene glycol dimethacrylate, 1-vinylimidazole, cyclohexyl methacrylate, 2-(dimethylamino)ethyl methacrylate, or glycidyl methacrylate, or any combination thereof.
[0037] In some embodiments, the one or more monomers comprise one or more monomers from the following Table 2.1 from Gleason, K. K. (2015) CVD Polymers: Fabrication of Organic Surfaces and Devices, pages 19-22, or a combination thereof:
[0038] In some embodiments, the one or more monomers comprise one or more monomers from the following table from Karen, Gleason Frontiers in Bioengineering and Biotechnology 2021, or a combination thereof:
[0039] n some embod ments, t e one or more monomers compr se one or more o the following:.
[0040] In some embodiments, the one or more monomers comprise one or more of the following: cyclotetrasiloxane; 4-vinylbenzyl chloride; allyl methacryate; 2- cyanoethyl acrylate; 2-dimethylamino ethyl methacrylate; 2-dimethylamino styrene; glycidal methacrylate; o- nitrobenzyl methacrylate; 1H,1H,2H,2H- perfluorodecylacrylate; 1,4- butanediol diacrylate; and triallyl phosphate.
[0041] In some embodiments, introducing vapor-phase reagents into the reactor comprises introducing the vapor-phase reagents to a maximum concentration that is below a structure-disrupting threshold of the LC. In some embodiments, introducing vapor-phase reagents into the reactor comprises introducing the vapor-phase reagent(s) to a concentration wherein the concentration is below a threshold concentration of the reagent(s) to cause structure- disrupting of the LC template(s) (e.g. cause phase transition of LC from a nematic phase to an isotropic phase). In some embodiments, introducing vapor-phase reagents into the reactor comprises introducing the vapor-phase reagent(s) to a concentration wherein the LC template(s) maintains one or more phases or forms selected from nematic, chiral nematic, smectic, polar smectic, chiral smectic, frustrated phases and discotic phases after introducing the concentration of the vapor-phase reagent(s).
[0042] In some embodiments of the inventive method, the LC is in, and remains in, the nematic phase.
[0043] In some embodiments, the LC does not enter isotropic phase during the method.
[0044] In some embodiments, the inventive method is performed within 30 to 400 minutes (e.g., 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121,122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 306, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 328, 329, 330, 331, 332, 333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 355, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 374, 375, 376, 377, 378, 379, 380, 381, 382, 383, 384, 385, 386, 387, 388, 389, 390, 391, 392, 393, 394, 395, 396, 397, 398, 399, or 400 minutes), including any and all ranges and subranges therein.
[0045] It is well within the purview of the skilled person to select an appropriate LC for use in the inventive method, and it is completed that any appropriate LC may be used.
[0046] In some embodiments, the LC is E7, Anisaldazine, 5CB, 8CB, DOBAMBC, MBBA, 8OCB, PAA, PYP906, or PCH5.
[0047] In some embodiments, the LC comprises the following components: .
[0048] In some embodiments, the LC comprises: 4-cyano-4'-n-pentyl-biphenyl C18H19N (5CB) (51 wt%, optionally ± 5% (e.g., ± 0.1, 0.2, 0.3, 0.4, 0.5, 1, 2, 3, 4, or 5%)); 4-cyano-4'-n-heptyl-biphenyl C20H23N (7CB) (25 wt%, optionally ± 5% (e.g., ± 0.1, 0.2, 0.3, 0.4, 0.5, 1, 2, 3, 4, or 5%)); 4-cyano-4'-n-oxyoctyl-biphenyl C21H25NO (80CB) (16 wt%, optionally ± 5% (e.g., ± 0.1, 0.2, 0.3, 0.4, 0.5, 1, 2, 3, 4, or 5%)); and 4-cyano-4''-n-pentyl-p-terphenyl C24H23N (5CT) (8 wt%, optionally ± 5% (e.g., ± 0.1, 0.2, 0.3, 0.4, 0.5, 1, 2, 3, 4, or 5%)).
[0049] In some embodiments, the LC is an LC as described in U.S. Patent No.7,666,661. In some embodiments, the LC is a thermotropic or lyotropic liquid crystal comprising one or more mesogens. In some embodiments, the LC exists in a form selected from nematic, chiral nematic, smectic, polar smectic, chiral smectic, frustrated phases, and discotic phases. In some embodiments, the LC comprises a mesogen selected from Table A below.Table A – Molecular Structure of Mesogens Suitable for Use in LC
[0050] In some embodiments, the invention utilizes one or more biocompatible mesogens (LCs). For example in some embodiments, the mesogens are as described in Albuquerque, H.M.T.; Santos, C.M.M.; Silva, A.M.S. Cholesterol-Based Compounds: Recent Advances in Synthesis and Applications Molecules 2019 24 116 and / or Boiko YA Kravchenko IANovikova, N.S. et al. Effects of Liquid Crystal Systems Based on Cholesterol Esters on Skin Permeability. Pharm Chem J 47, 393–396 (2013).
[0051] In some embodiments, the inventive method comprises introducing polymerization initiator into the reactor. This step may be referred to as “initiating polymerization”, and includes, in addition to introducing polymerization initiator, other methods of polymerization initiation. For example, in some embodiments, polymerization is initiated via photoinitiation (e.g., with light). In particular embodiments, polymerization is initiated by introducing polymerization initiator into the reactor.
[0052] In some embodiments, the polymerization initiator generates a radical that initiates a free radical polymerization upon contacting the reagents in or on the LC.
[0053] In some embodiments, the radical is generated by contacting the polymerization initiator with a heated filament array. In some embodiments, the radical is generated by contacting the polymerization initiator with a heated filament array at a temperature of less than or equal to 450 °C. For example, in some embodiments, the heated filament array is at a temperature of 150 to 400 °C (e.g., 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 306, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 328, 329, 330, 331, 332, 333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 355, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 374, 375, 376, 377, 378, 379, 380, 381, 382, 383, 384, 385, 386, 387, 388, 389, 390, 391, 392, 393, 394, 395, 396, 397, 398, 399, or 400 °C), including any and all ranges and subranges therein (e.g., 200 to 350 °C, 250 to 290 °C, etc.).
[0054] In some embodiments, the inventive method comprises introducing an additional agent into the reactor. For example, in some embodiments, the additional agent is a therapeutic agent (e.g., an anti-cancer agent, such as chlormethine)
[0055] In some embodiments, the inventive method comprises: a) introducing an additional agent into the reactor; b) introducing vapor-phase reagents into the reactor; c) introducing polymerization initiator into the reactor; and d) forming polymer particles via chain-growth polymerization
[0056] In some embodiments, a) is performed before b). In some embodiments, b) is performed before a). In some embodiments, a) and b) are performed at the same time. In various embodiments, c) is performed after b). In some embodiments, c) is performed after a). In some embodiments, c) is performed before a).
[0057] In some embodiments, introducing an additional agent into the reactor comprises vaporizing the additional agent into the reactor.
[0058] In some embodiments, introducing an additional agent into the reactor comprises sublimating the additional agent into the reactor.
[0059] In some embodiments, the additional agent comprises: a therapeutic agent (for example, an anti-cancer agent, such as a chemotherapeutic agent, e.g., chlormethine, 5-fluorouracil, camustine, ifosfamide, thiotepa, etc.); an anti-cancer agent (for example, curcumin, kaempferol, paclitaxel, resveratrol, silamarin, vincristine, etc.); an antimicrobial agent (for example, artemisinim, caffeic acid, capsaicin, coumarin, eugenol, menthol, etc.); an anti-inflammatory agent (for example, capsaicin, colchicine, curcumin, epigallocatechin-3-gallate, quercetin, resveratrol, etc.);a neuroprotective agent (for example, bacoside A, bilobalide, curcumin, galantamine, ginsenosides, withaferin A); an antioxidant agent (for example, curcumin, cyanidin, gingerol, ginkgo biloba, glycyrrhizin, quercetin, etc.); a cardiovascular protection agent (for example, berberine, curcumin, dihydrotanshinone, quercetin, resveratrol, etc.); essential oils, metals (silver ions, copper ions), zinc oxide, graphene oxide or carbon nanotubes, photoactive compounds (titanium dioxide, benzophenone, MoS2,MnO2, zinc oxide, gold nanoparticles), eugenol, menthol, eucalyptol, capsaicin, polyphenols, etc.; a fuel agent, for example, cerium oxide+H2O2, calcium carbonate + acid, catalysts (e.g., aluminum oxide, copper oxide, silver oxide, iron oxide, cobalt oxide), etc.; or a diagnostic and / or imaging agent, for example, fluorescent molecules, iodine, barium, supramagnetic iron oxide, bismuth, gold, gadolinium-containing probes, (ultrasmall) superparamagnetic iron oxide nanoparticles [(US)SPIO], paramagnetic liposomes and polymers, paraCEST agents, hyperpolarized probes, iodine-base micelles and liposomes, barium-based nanoparticles, gold-based nanoparticles, bismuth nanoparticles, targeted and non-targeted as- filled microbubbles, nanobubbles, air-releasing polymers, near-infrared fluorochrome-labelled nanoparticles, quantum dots, fluorescent nanoparticle probes, gold nanoparticles, gold nanorods, carbon nanotubes, fluorescent / dye-loaded nanoparticles, radioactive contrast agents (e.g., radiolabeled gold nanoshells), polymeric nanoparticles, technetium-labelled gold nanoparticles, indium-labelled liposomes, nano- and microcolloids, etc., or a combination thereof.
[0060] In some embodiments, the polymer particles (which may also be referred to as “polymer structures”) are in the form of spheres, microgel, spheroids, discs, hemispherical domes, or fibers.
[0061] In embodiments of the invention that use a polymerization initiator, any art acceptable polymerization initiator may be used. In some embodiments, the polymerizationinitiator is tert-butyl peroxide vapor that contacts a heated filament array to generate tert-butoxyl radicals that initiate free radical polymerization.
[0062] In some embodiments, the substrate is a substrate as described in U.S. Patent No. 7,666,661. In some embodiments, the substrate is: an inorganic crystal or inorganic glass (e.g., LiF, NaF, NaCl, KBr, KI, CaF2, MgF2, HgF2, BN, AsS3, ZnS, Si3N4 and the like); an inorganic oxide (e.g., Cs2O, Mg(OH)2, TiO2, ZrO2, CeO2, Y2O3, Cr2O3, Fe2O3, NiO, ZnO, Al2O3, SiO2 (glass), quartz, In2O3, SnO2, PbO2and the like); a metal (e.g., gold, silver, platinum, palladium, nickel, copper, etc.); or an organic polymer (e.g., polydimethylsiloxane, polyethylene, polyacrylonitrile, cellulosic materials, polycarbonates and polyvinyl pyridinium, polyalkenes (e.g., polyethylene, polyisobutene, polybutadiene), polyacrylics (e.g., polyacrylate, polymethyl methacrylate, polycyanoacrylate), polyvinyls (e.g., polyvinyl alcohol, polyvinyl acetate, polyvinyl butyral, polyvinyl chloride), polystyrenes, polycarbonates, polyesters, polyurethanes, polyamides, polyimides, polysulfone, polysiloxanes, polyheterocycles, cellulose derivative (e.g., methyl cellulose, cellulose acetate, nitrocellulose), polysilanes, fluorinated polymers, epoxies, polyethers and phenolic resins (See, Cognard, J. ALIGNMENT OF NEMATIC LIQUID CRYSTALS AND THEIR MIXTURES, in Mol. Cryst. Liq. Cryst.1:1-74 (1982)).
[0063] In some embodiments, the substrate surface is prepared as described in U.S. Patent No.7,666,661.
[0064] In some embodiments, the substrate comprises a coating or layer (e.g., an organic layer) as described in U.S. Patent No.7,666,661.
[0065] In some embodiments of the inventive method, the LC is on a substrate that is cooled. In some embodiments, the substrate is at a temperature of -10 to 80 °C (e.g., -10, -9, -8, - 7, -6, -5, -4, -3, -2, -1, 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, or 80 °C), including any and all ranges and subranges therein. In some embodiments, the synthesis (e.g. polymerization) conditions include a temperature below a Nematic-to-Isotropic transition temperature (K) of the LC. In some embodiments, the temperature is also above a threshold phase transition temperature to crystalline(solid) of theLC). In some embodiments, the synthesis (e.g. polymerization) conditions include a concentration (or a partial pressure) of vapor-phase reagents (e.g. one or more monomers), polymerization initiator(s) and / or additional agent below a threshold concentration (or a threshold partial pressure) to cause Nematic-to-Isotropic transition of the LC.
[0066] In some embodiments, the substrate is functionalized (e.g., has a functionalized coating thereon). Persons skilled in the art are able to identify acceptable functionalizations or coatings, and it is contemplated that all such embodiments may be used in the invention. In some embodiments, the substrate comprises a perfluorinated polymer or poly(divinyl benzene).
[0067] In some embodiments, the substrate comprises an omniphobic coating.
[0068] In some embodiments, the polymer particles have a size (or an average size) of 0.01 nm to 1,000,000 nm (e.g., 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.10, 0.11, 0.12, 0.13, 0.14, 0.15, 0.16, 0.17, 0.18, 0.19, 0.20, 0.21, 0.22, 0.23, 0.24, 0.25, 0.26, 0.27, 0.28, 0.29, 0.30, 0.31, 0.32, 0.33, 0.34, 0.35, 0.36, 0.37, 0.38, 0.39, 0.40, 0.41, 0.42, 0.43, 0.44, 0.45, 0.46, 0.47, 0.48, 0.49, 0.50, 0.51, 0.52, 0.53, 0.54, 0.55, 0.56, 0.57, 0.58, 0.59, 0.60, 0.61, 0.62, 0.63, 0.64, 0.65, 0.66, 0.67, 0.68, 0.69, 0.70, 0.71, 0.72, 0.73, 0.74, 0.75, 0.76, 0.77, 0.78, 0.79, 0.80, 0.81, 0.82, 0.83, 0.84, 0.85, 0.86, 0.87, 0.88, 0.89, 0.90, 0.91, 0.92, 0.93, 0.94, 0.95, 0.96, 0.97, 0.98, 0.99, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272,273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 306, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 328, 329, 330, 331, 332, 333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 355, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 374, 375, 376, 377, 378, 379, 380, 381, 382, 383, 384, 385, 386, 387, 388, 389, 390, 391, 392, 393, 394, 395, 396, 397, 398, 399, 400, 401, 402, 403, 404, 405, 406, 407, 408, 409, 410, 411, 412, 413, 414, 415, 416, 417, 418, 419, 420, 421, 422, 423, 424, 425, 426, 427, 428, 429, 430, 431, 432, 433, 434, 435, 436, 437, 438, 439, 440, 441, 442, 443, 444, 445, 446, 447, 448, 449, 450, 451, 452, 453, 454, 455, 456, 457, 458, 459, 460, 461, 462, 463, 464, 465, 466, 467, 468, 469, 470, 471, 472, 473, 474, 475, 476, 477, 478, 479, 480, 481, 482, 483, 484, 485, 486, 487, 488, 489, 490, 491, 492, 493, 494, 495, 496, 497, 498, 499, 500, 1000, 2000, 3000, 4000, 5000, 6000, 7000, 8000, 9000, 10000, 11000, 12000, 13000, 14000, 15000, 16000, 17000, 18000, 19000, 20000, 21000, 22000, 23000, 24000, 25000, 26000, 27000, 28000, 29000, 30000, 31000, 32000, 33000, 34000, 35000, 36000, 37000, 38000, 39000, 40000, 41000, 42000, 43000, 44000, 45000, 46000, 47000, 48000, 49000, 50000, 51000, 52000, 53000, 54000, 55000, 56000, 57000, 58000, 59000, 60000, 61000, 62000, 63000, 64000, 65000, 66000, 67000, 68000, 69000, 70000, 71000, 72000, 73000, 74000, 75000, 76000, 77000, 78000, 79000, 80000, 81000, 82000, 83000, 84000, 85000, 86000, 87000, 88000, 89000, 90000, 91000, 92000, 93000, 94000, 95000, 96000, 97000, 98000, 99000, 100000, 200000, 300000, 400000, 500000, 600000, 700000, 800000, 900000, or 1000000 nm), including any and all ranges and subranges therein.
[0069] In some embodiments, the temperature at which polymerization occurs is from - 20 to 40 °C (e.g., -20, -19, -18, -17, -16, -15, -14, -13, -12, -11, -10, -9, -8, -7, -6, -5, -4, -3, -2, - 1, 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, or 40 °C), including any and all ranges and subranges therein.
[0070] In some embodiments, temperatures employed during the inventive method do not exceed 450° C.
[0071] In some embodiments, the inventive methods provides beneficial biocompatibility and bio passivation properties, for example: retention of carboxyl, pyridine, imidazole, double bonds, or amine groups: immobilization of enzymes, peptides, proteins, polysaccharides, other bioactive molecules, or be further derivatized into biocompatible polymers like zwitterionic polymers, amphiphilic copolymers. In some embodiments, the inventive method allows for retention of hydroxyl groups, which has hydrophilicity and swelling property implications.
[0072] In some embodiments, the inventive method comprises one or more post- deposition modification reactions. For example, post-deposition modification reactions are possible for certain polymer particles synthesized using this technology. Such post-deposition modifications include derivatization via ring-opening reactions, hydrolysis of the side chain (e.g., of a methacrylate or acrylate), and the aforementioned functionalization for biocompatible and bio-passivation properties.
[0073] In some embodiments, the inventive method is performed according to the synthesis conditions listed in Table 2 (or within ± 10% of any recited condition / value): Table 2: Synthesis conditions – Range of parameters compatible / accessible for iCVD-LC polymerization (calculated non-limiting LCs) Liquid Crystal* Nematic-to- Partial Pressure Partial Pressure Range #*molecular structures of these LCs can be found below in the list point 3 #calculations based on monomer cyclohexyl methacrylate (CHMA) #calculations based on initiator di-tert-butyl peroxide (TBPO)
[0074] In some embodiments, the inventive method does not comprise performing anisotropic polymerization.
[0075] In some embodiments, the inventive method comprises using in-situ microscopy to monitor the chain-growth polymerization. For example, in some embodiments, a microscope captures LC optical output during the iCVD chain growth polymerization. In some embodiments, output / data from the microscope is read by an artificial intelligence- (AI) powered algorithm to provide information regarding materials and their properties (e.g., particle size, shape, morphology etc.).
[0076] In a second aspect, the invention provides a polymer particle prepared according to the first aspect of the invention.
[0077] In some embodiments, the invention provides a polymer particle comprising: polymer material; and optionally, mixed with the polymer material, an additional agent (e.g., a therapeutic agent).
[0078] In some embodiments, the additional agent is homogeneously or heterogeneously dispersed within, or mixed within, the polymer material.
[0079] In some embodiments, the polymer particles of the present invention and methods of making the same find use in: o Drug delivery o Injectable implants o Virus detectiono Toxins / toxic metals detection o Soft robotics o Materials enhancements (e.g., durability enhancement, anti-corrosion) o Bioactive food compounds o Release of protective or nutritional elements in plants / agriculture o Environmental remediation o Nanolenses for enhanced microscopy o Adhesives o Antireflective surfaces o Fuel efficiency EXAMPLES
[0080] The invention will now be illustrated, but not limited, by reference to the specific embodiments described in the following examples.
[0081] Materials
[0082] Nematic LC, E7 (nematic mixture of cyanobiphenyls and terphenyls) was obtained from EMD Millipore (Billerica, MA). Divinylbenzene (technical grade, 80%), hexane (CHROMA SOLV ® grade) and octyltrichlorosilane (OTS), were purchased from Sigma- Aldrich (St. Louis, MO) and used as received. Polyimide and Thinner solutions were purchased from HD MicroSystems (Parlin, NJ). Ethanol (anhydrous, 200 proof) was purchased from VWR International (Radnor, PA) and used as received. TEM copper grids and quartz slides were purchased from Electron Microscopy Sciences (Hatfield, PA).
[0083] LC templates preparation
[0084] Substrate Preparation Glass Substrates: A glass slide was first incubated in Alconox solution and sonicated for 10 minutes, followed by a thorough rinse in deionized water (DI-H2O) and ethanol.OTS Functionalization: Glass substrates were incubated in a hexane solution of OTS (324uL in 140mL hexane) for 30 min followed by rinsing with chloroform for 1 min and then thoroughly rinsed in deionized water (DI-H2O) and ethanol. Rubbed PI Functionalization: Polyimide (PE2555) and Thinner solutions were mixed (1:1 wt / wt) in a vial and vortexed for 30 seconds. The mixture was filtered with a 0.45- ^m pore size filter. Glass substrates (rinsed with ethanol) were spin coated with the filtered PI + thinner mixture (3000RPM for 25 seconds). The surfaces were baked at 275C for 1 hr and then rubbed unidirectionally with a velvet cloth.
[0085] Preparation of LC Templates A TEM grid (18 μm in thickness) was placed on the above-described substrates and filled with E7. Excess LC was then removed from the grid using a capillary tube, yielding a 18 μm thick LC layer for all the above mentioned systems.
[0086] iCVD polymerization in LC and its real-time monitoring
[0087] A fundamental limitation of LC-templated polymerization has been the disruption of the LC template structure by loading monomers into the LC at a concentration sufficient to sustain the polymerization. To minimize perturbation of the LC phase by monomer dissolution, we chose iCVD based on its continuous and precise vapor-phase delivery of monomers. Furthermore, iCVD is compatible with a large library of functional monomers, enabling access to a wide palette of polymers with diverse chemical functionalities. While iCVD is presently known for its conformal coating ability over solid substrates, Gupta et al4have used iCVD in isotropic solvents such as ionic liquids and silicone oil to form 3D polymeric structures. For insoluble monomers like 1H,1H,2H,2H-perfluorodecyl acrylate (PFDA), polymerization occurred predominantly at the vapor-liquid interface; while soluble monomers such as 2-hydroxyethyl methacrylate (HEMA) infiltrate the bulk liquid, giving rise to a liquid-polymer gel.
[0088] During iCVD in LC (as shown in FIG. 1), the monomer DVB and initiator tert- butyl peroxide (TBPO) are vaporized and delivered at controlled rates into the reactor under medium-to-high vacuum (150 mTorr). Detailed deposition conditions are shown in the following Table I:TABLE I: iCVD Reaction Conditions PDVB PTBPO PAr TStage Time LC LC Particle shape 0 Phase orientation s l s
[0089] TBPO is thermally decomposed to form tert-butoxide (TBO) radicals, with the energy supplied by a filament array that is resistively heated to ~270ºC. The array is suspended over a cooled stage (kept at 20ºC), on which the nematic LC, E7, is placed. The DVB vapor and TBO radicals partition into the LC, which subsequently react to initiate polymerization via the chain-growth mechanism. To ensure that the dissolution of DVB and TBO, and the polymerization of DVB did not disrupt the alignment of the LC medium, a custom long focal range microscope was leveraged to observe the real-time progression of these processes, as shown in FIG.2.
[0090] The upper bound of DVB concentration in the LC template was identified, above which the nematic LC transitioned to an isotropic phase with no long-range orientational order, as demonstrated from a series of snapshots taken in-situ (FIG.2, part A). The orientational order of LC was determined using cross polarizers in the in-situ microscope. The bright appearance at t = 0 indicated the hybrid orientation of LC that is typically observed over a glass substrate (FIG.2, A h i h l f ) h 40 d bl l i di d i i li id(FIG.2, part A, schematic on the right; the blue color was due to light scattering from the bottom of the reactor when viewed using crossed polars). As such, the threshold DVB concentration was identified, expressed as the DVB partial pressure in the vapor phase directly above the LC, i.e., PDVB, to be 30.5 mTorr (see Table II for details). TABLE II: Reactor Conditions to Probe for LC Structure Disruptions During iCVD Species Partial Pressure (mTorr) Stage Temperature (0C) LC Phase
[0091] The nematic to isotropic transition was signified by formation of isotropic droplets that we observed to commonly accompany the phase transition. The PDVB of 26.9 mTorr was used for all subsequent experiments. This partial pressure was used to ensure that LC stays in the nematic phase to provide the templating effect, while achieving a high rate of polymerization. For the initiating species, i.e., TBPO and TBO radicals, no such transition was observed for PTBPO values up to 90 mTorr. PTBPOof 3.8 mTorr was used throughout this study.
[0092] iCVD polymerization was performed in the nematic LC by co-flowing DVB and TBPO (see Table I for detailed flowrates, temperatures, and pressure during iCVD). 50 minutes after the start of the reaction (by turning the filament array to decompose TBPO into radicals), Formation of phase separated polymeric clusters were observed (dark dots shown in FIG.2, part B) in LC (the background). It was confirmed that these dark dots correspond to polymeric clusters of different shapes using ex-situ microscopy images and SEM.
[0093] The real-time monitoring also revealed a surprising effect of the polymerization, i.e., a transition of the LC alignment (on glass) from hybrid (bright appearance) to homeotropic (dark appearance) over the course of 45 minutes of DVB polymerization (FIG. 2, part C). The transition was confirmed by characterizing LC films obtained before (hybrid) and after (homeotropic) 65 minutes of iCVD using ex-situ orthoscopic and conoscopic polarized light i ( h i FIG 3) T l th i i f th t iti ti l llprepared with two glass slides coated using the LC-templated iCVD process, capping the top and bottom of a E7 film (see FIG.3, part C). It was theorized that if the orientational transition had occurred via reorientation of the easy axis (preferred orientation) of the LC at the confining surfaces (e.g., due to polymeric structure at a surface) then the LC would maintain its perpendicular alignment in the optical cell (with dark appearance under cross-polarized light). However, the optical cell showed a bright texture (FIG.3, part F) corresponding to a planar alignment (FIG.3, part I). Therefore, the transition in FIG. 2, part C was attributed to a low LC surface anchoring energy generated by the iCVD polymerization at the LC-substrate interface, such that the anchoring energy at the air-LC interface dictates the homeotropic alignment of the entire LC film, as shown in FIG.2, part C. This guided the investigation into the LC-substrate interface and the discovery of the role it plays in particle shape evolution.
[0094] Discovery of shape evolution during iCVD polymerization in LC and elucidation of mechanisms
[0095] Morphology progression for DVB polymerization in LC
[0096] To demonstrate that the polymer morphology evolves over time, the iCVD polymerization in LC was stopped (on glass coated by polyimide (PI)) at predetermined times (i.e., 30, 65, 90, 120, and 180 minutes). The progression of polymeric structures observed during in-situ monitoring was confirmed via ex-situ optical micrographs (FIG.4, parts A-D and FIG. 5). To characterize the microscopic progression of polymer morphology, bulk LC was removed by washing samples in ethanol and examined the LC-substrate interface at each time point using SEM. A Critical Point Drying (CPD) procedure was used to demonstrate that the ethanol washing step did not change the polymer morphology (see FIG. 6). The SEM images illustrate the detailed morphology progression for DVB polymerization in LC over the course of 180 minutes (FIG.4, parts E-H). The spatiotemporal evolution of the chemical composition of the polymer structures was determined using laser confocal Raman microscopy (FIG.4, parts I-M). As benchmarks, we first obtained the Raman spectra for nematic E7 (FIG.4, part I; see FIG.7 for molecular structure of constituents for the E7 LC mixture) and DVB monomer (FIG.4, part J), which agreed well with literature. The peaks at 1609 cm-1(indicated by leftmost dashed line) and 2230 cm-1(indicated by rightmost dashed line) in the E7 spectrum correspond to skeletal stretch of phenyl rings and CN stretch, respectively. The CN stretch was used (2230 cm-1) to quantify E7 because it does notoverlap with DVB peaks. DVB monomer also has a peak at 1609 cm-1due to its benzene ring; the peak at 1632 cm-1(indicated by middle dashed line) corresponds to C=C stretch of unreacted vinyl group, which does not overlap with peaks of E7. The C=C peak was hence used to estimate the degree of reaction of the two vinyl bonds in DVB, which was correlated to the polymeric morphology formed in the iCVD in LC process (FIG.4, parts K-M). All shaped particles contained both E7 and pDVB.
[0097] The reaction mixture is initially homogenous, as evidenced by our in-situ observations revealing the absence of liquid-liquid phase boundary development during the continuous delivery of DVB into E7. Polymerization is initiated via the delivery of TBO radicals. Nanospheres are the dominant shape during the early-stage iCVD in LC polymerization (FIG.4, part E). The formation of nanospheres was attributed to the phase separation of pDVB from the marginal solvent (i.e., E7), building upon the mechanism of precipitation polymerization of DVB in isotropic solvents. The nanospheres have 24% unreacted vinyl groups (FIG.4, part K), which is common for precipitation polymerization. However, the percentage is lower than that for pDVB synthesized via conventional iCVD (i.e., 52%), which is likely a result of the low threshold concentration of DVB in nematic LC and the diffusion-limited reaction conditions. The nanoparticles have an average diameter of 160 ^ 80 nm (FIG.4, part N), calculated using a sample size of 15417 particles. That size distribution was further corroborated by DLS (FIG. 8). This average size is an order-of-magnitude smaller than that obtained in common precipitation polymerization, i.e., 2-5 μm, which was attributed to the combined effects of (i) the marginal solvency of pDVB in nematic E7, and (ii) the poor dispersion of the nanospheres that are larger than the extrapolation length of E7 (~100 nm), owing to the elastic energy that arises from director strain. (The extrapolation length of LC is defined as the ratio of a characteristic Frank elastic constant to the LC-surface anchoring energy density, which has also been postulated to determine the diameters of nanofibers synthesized in LC.) This conclusion is supported by the prior observation that nanospheres with similar sizes (300 ^ 100 nm) have been obtained via polymerization of crosslinkers in LC.
[0098] In contrast to precipitation polymerization, during which pDVB seed particles form mainly during early-stage polymerization, nanospheres continue to form and precipitate during the entire iCVD process in the LC, as seen from their presence at each time point (e.g., on top and d th l i t t th t l t f d ith b l ti i th l ft fFIG 4, parts E-H). This observation highlights a key difference between the batch-wise reaction in precipitation polymerization, where solutions were preloaded with a finite amount of initiator and monomer, and the continuous reaction was performed with constant delivery of DVB and TBPO into nematic E7 throughout the reaction time.
[0099] The precipitated nanospheres were observed to aggregate at the LC-substrate interface, forming colloidally stable microgels after 65 minutes of iCVD polymerization (FIG.4, part F). Drawing an analogy to precipitation polymerization again, the precipitated nanospheres can be viewed as building blocks, i.e., monomers, which aggregate to form a microgel, analogous to an oligomer. Microgels continue to grow by further capturing nanospheres and by heterogeneous polymerization (FIG. 4, part E and F). While precipitation polymerization often leads to spherical microgels, the shape of microgels observed in FIG. 4, part F is guided by the local orientation of the LC These microgel clusters have 32% unreacted vinyl groups (FIG.4, part L), which is higher than the precipitated nanospheres and likely a result of the heterogeneous polymerization. [000100] Similar to precipitation polymerization, discrete microparticles ultimately emerge from microgels, as observed after 90 minutes of iCVD polymerization (FIG. 4, part G). Nevertheless, distinct from precipitation polymerization, which typically yields uniform spherical particles, iCVD polymerization in LC achieves an unprecedented morphological diversity, including microspheres, micro-spheroids, and micro-discs at the LC-substrate interface (FIG. 4, part H). The current state of the art suggests that spheroids and discs have not been formed previously by polymerizing DVB. [000101] Raman microscopy revealed that pDVB microparticles have 45% unreacted vinyl groups (FIG.4, part M), higher than those of nanospheres and microgel clusters. This significant increase is likely due to auto-acceleration that is commonly observed in free-radical polymerization with phase separation, including that in LC. It was postulated that phase separation creates a polymer-rich phase (which ultimately leads to discrete microparticles) and a solvent-rich phase, with DVB monomer preferentially partitioning into the polymer-rich phase and thus creating an environment that resembles bulk polymerization. With the high monomer concentration and high viscosity in the polymer-rich phase, chain termination and crosslinking are reduced drastically, leading to a high % unreacted vinyl groups like those shown in FIG.4, partM. Upon further polymerization (from 120 to 180 minutes), the microparticles grow from 2.22 ^ 0.57 μm to 3.31 ^ 0.90 μm in size (FIG.4, part N). [000102] The observations via the in-situ microscope, SEM, and Raman microscopy point to a strategy to achieve shape-controlled polymer particles simply by controlling the polymerization reaction time in LC. The pDVB particles undergo a pathway of nanosphere (in bulk LC) to microgel, to microsphere and micro-discs at the LC-substrate interface as the iCVD polymerization in LC progresses. The formation of a porous film at the LC-vapor interface was also observed for longer reaction times (e.g., longer than 120 mins), as shown in FIG.9. Similar observations have been made during iCVD in isotropic liquids and is likely due to monomer adsorption at the LC- vapor interface. Next, the focus shifted to unraveling the effect of the LC anisotropy on the morphology of the polymer particles formed at the LC-substrate interface by performing iCVD in LC with three different orientations. [000103] Role of LC in shaping and directing DVB polymerization at LC-substrate interface [000104] To understand the effect of LC anisotropy on shaping the microgels, iCVD in E7 films supported by three types of solid substrates were investigated: glass functionalized by OTS, glass, and glass functionalized with PI rubbed in one direction. E7 aligns perpendicularly at the air-LC interface. OTS functionalized glass is known to lead to perpendicular anchoring [as shown in bottom-left (x-z plane) and bottom-right (x-y plane) panels in FIG. 10, part A], which was confirmed by the dark cross-polarized optical micrograph (top of FIG. 10, part A). The glass surface (cleaned with alconox and ethanol prior to use) leads to planar anchoring with random azimuthal orientation, and a hybrid orientation in the cross-section (FIG.10, part B). Rubbed PI- functionalized glass leads to planar anchoring with uniform azimuthal orientation of E7 along the direction of rubbing, which was also confirmed using cross-polarized optical imaging (FIG. 10, part C). [000105] The iCVD polymerization undergoes similar growth stages in LC that is supported by OTS-functionalized glass, glass, and PI-functionalized glass ( see FIGS.11 to 14 for a detailed discussion on polymer morphology progression during iCVD in LC on the other two surfaces). However, intriguingly at the interfacial microgel stage, the LC anisotropy at the LC-substrate interface shaped the microgel clusters, while translating its long-range molecular order into the ordering of the clusters.[000106] The SEM images of the microgels formed on the three substrates (FIG.10, parts D- F) clearly indicate the directed growth of disparate polymer morphology. That apparent shape anisotropy is quantitatively demonstrated through a statistical analysis of the frequency of appearance of the microgel clusters with distinct aspect ratios on each substrate . Dome-shaped hemispheres (aspect ratio = 1) emerge on OTS-functionalized glass (FIG.10, parts D and G) due to the homeotropic E7 alignment. In contrast, elongated particles with higher aspect ratios dominate in E7 with hybrid alignment, i.e., on glass and rubbed PI-functionalized glass. Specifically, unmodified glass leads to randomly aligned microgels (FIG. 10, parts E and H), whereas directional microgel (oriented along the presumed direction of rubbing) forms on a rubbed PI surface (FIG.10, parts F and I). [000107] Based on this observation at the micron-scale, large-scale particle directionality analysis was performed at the length scale of a few millimeters, on polymer clusters observed in optical micrographs (FIG. 10, parts J-L. The directionality histograms show that the microgels formed on OTS-functionalized glass and glass are randomly aligned (FIG.10, parts M and N), and those formed on rubbed PI are aligned at an angle of 36º (FIG. 10, part O), i.e., the direction of rubbing. This directionality is further seen through the continuous alignment of microgels over the length scale of 3.05 mm (see FIG.15). [000108] Synthesis capabilities and potential applications [000109] Building upon the mechanistic understanding of LC-templated iCVD polymerization, a host of polymer morphologies were achieved simply by tuning the reaction time and LC alignment (FIG.16, part A). By limiting the polymerization time to 30 minutes while using a homeotropic or a hybrid LC alignment, predominantly nanoparticles were obtained. At 65 minutes, dome-shaped particles were obtained in homeotropic LC, whereas elongated microgels were obtained in LC with hybrid alignments. Microparticles with different shapes (spheres, spheroids and, discs) were synthesized by performing iCVD for 120-180 minutes in LC with hybrid alignment. Each polymer morphology is associated with its characteristic feature size (e.g., the diameter of nanoparticles is ~160 nm and that of microparticles is 2-3 ^m). [000110] The iCVD conditions (i.e., monomer and initiator flow rates, total chamber pressure, stage and temperatures) were kept constant in these depositions (see Table I for detailed deposition conditions). Furthermore, iCVD is compatible with a library of more than 70 monomerchemistries, which can be harnessed to uncover the endless combinations of morphology and organic functionality that may be accessible using the reported approach. [000111] These shape-controlled particles have many advantages in a broad range of applications. Here their potential as drug delivery vehicles is demonstrated. The E7 encapsulated in the particles (as indicated by the CN peak at 2230 cm-1in their Raman spectra, FIG.4, parts K- M), can be viewed as a proxy for therapeutics. To demonstrate the ability to release similar molecules, the Raman spectra for micron-sized spheroid particles were studied before and after immersing in ethanol for 10 mins. Disappearance of the CN peak at 2230 cm-1after release (FIG. 16, part B) indicates successful release of the encapsulated E7 molecules with no change in the polymer composition (i.e., % unreacted vinyl bonds) (see FIG. 12). Although the release conditions will likely need to be modified to adapt the particles to biomedical applications, this proof-of-principle points to their exciting future potential. The heterogeneity in particle sizes shown in FIG. 16, part A and B is noted, which can be desirable for programming the pharmacokinetics using a carefully selected collection of such particles. [000112] Conclusion [000113] The foregoing embodiments demonstrate a two-step pathway governing the synthesis of polymeric structures in an anisotropic medium, which led to disparate morphologies, using DVB as the monomer for demonstration. Testing revealed that LC-templated iCVD polymerization goes around the precipitation growth pathway twice, once in bulk and the second time at the LC-substrate interface. This two-step pathway provides an effective framework for understanding the mechanism of polymerization in anisotropic solvents. It also enabled the achievement of a host of polymer morphologies previously inaccessible in isotropic solvents. The templating effects of LC were demonstrated using three types of LC alignments, carefully selected to have different orientation near the LC-substrate interface, which enabled the imprinting of LC anisotropy on the polymeric microgels, a step that lends itself towards shape programmability. [000114] The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprise” (and any form of comprise, such as “comprises” and “comprising”), “have” (and any form of have,such as “has” and “having”), “include” (and any form of include, such as “includes” and “including”), “contain” (and any form contain, such as “contains” and “containing”), and any other grammatical variant thereof, are open-ended linking verbs. As a result, a method or device that “comprises”, “has”, “includes” or “contains” one or more steps or elements possesses those one or more steps or elements, but is not limited to possessing only those one or more steps or elements. Likewise, a step of a method or an element of a composition or article that “comprises”, “has”, “includes” or “contains” one or more features possesses those one or more features, but is not limited to possessing only those one or more features. [000115] As used herein, the terms “comprising,” "has," “including,” "containing," and other grammatical variants thereof encompass the terms “consisting of” and “consisting essentially of.” [000116] The phrase “consisting essentially of” or grammatical variants thereof when used herein are to be taken as specifying the stated features, integers, steps or components but do not preclude the addition of one or more additional features, integers, steps, components or groups thereof but only if the additional features, integers, steps, components or groups thereof do not materially alter the basic and novel characteristics of the claimed composition, device or method. [000117] All publications cited in this specification are herein incorporated by reference as if each individual publication were specifically and individually indicated to be incorporated by reference herein as though fully set forth. [000118] Subject matter incorporated by reference is not considered to be an alternative to any claim limitations, unless otherwise explicitly indicated. [000119] Embodiments of the inventive method are distinguished from the disclosures within the references discussed herein. [000120] Where one or more ranges are referred to throughout this specification, each range is intended to be a shorthand format for presenting information, where the range is understood to encompass each discrete point within the range, and further to encompass any subrange within the range between any discrete point within the range and any other discrete point within the range as if the same were fully set forth herein[000121] While several aspects and embodiments of the present invention have been described and depicted herein, alternative aspects and embodiments may be affected by those skilled in the art to accomplish the same objectives. Accordingly, this disclosure and the appended claims are intended to cover all such further and alternative aspects and embodiments as fall within the true spirit and scope of the invention.
Claims
CLAIMS 1. A method of synthesizing polymer particles, said method comprising, in a reactor having a substrate with a liquid crystal (LC) disposed thereon: introducing vapor-phase reagents into the reactor; contacting the reagents with the LC, dissolving the reagents in the LC, or a combination thereof; initiating polymerization; and forming polymer particles via chain-growth polymerization.
2. The method according to claim 1, wherein said introducing vapor-phase reagents into the reactor comprises introducing the vapor-phase reagents to a maximum concentration that is below a structure-disrupting threshold of the LC.
3. The method according to claim 1, wherein, during said method, the LC is in, and remains in, nematic phase.
4. The method according to claim 1, wherein the LC does not enter isotropic phase during the method.
5. The method according to claim 1, wherein the method is performed within 30 to 400 minutes.
6. The method according to claim 1, wherein the polymer particles are in the form of spheres, microgel, spheroids, discs, hemispherical domes, or fibers.
7. The method according to claim 1, wherein the LC is E7, Anisaldazine, 5CB, 8CB, DOBAMBC, MBBA, 8OCB, PAA, PYP906, or PCH5.
8. The method according to claim 1, wherein the LC comprises the following components:.
9. The method according to claim 1, wherein the LC comprises: 51 wt% 4-cyano-4'-n-pentyl-biphenyl C18H19N (5CB); 25 wt% 4-cyano-4'-n-heptyl-biphenyl C20H23N (7CB); 16 wt% 4-cyano-4'-n-oxyoctyl-biphenyl C21H25NO (80CB); and 8 wt% 4-cyano-4''-n-pentyl-p-terphenyl C24H23N (5CT).
10. The method according to claim 1, wherein the vapor-phase reagents include one or more monomers.
11. The method according to claim 10, wherein the one or more monomers comprise 2- hydroxyethyl methacrylate, divinylbenzene, 4-vinylpyridine, benzyl methacrylate, ethylene glycol dimethacrylate, 1-vinylimidazole, cyclohexyl methacrylate, 2-(dimethylamino)ethyl methacrylate, or glycidyl methacrylate, or any combination thereof.
12. The method according to claim 1, wherein said initiating polymerization comprises introducing polymerization initiator into the reactor, and wherein the polymerization initiator generates a radical that initiates a free radical polymerization upon contacting the reagents in or on the LC.
13. The method according to claim 12, wherein the radical is generated by contacting the polymerization initiator with a heated filament array.
14. The method according to claim 1, further comprising:introducing an additional agent (e.g., a therapeutic agent, for example, an anti-cancer agent, such as chlormethine) into the reactor.
15. The method according to claim 14, wherein the method is performed in the following order: introducing the additional agent into the reactor; introducing vapor-phase reagents into a reactor; introducing polymerization initiator into the reactor; and forming polymer particles via chain-growth polymerization.
16. The method according to claim 14, wherein said introducing an additional agent into the reactor comprises sublimating the additional agent into the reactor.
17. The method according to claim 14, wherein after the additional agent and vapor-phase reagents are introduced into the reactor, the additional agent disperses on or dissolves within the LC.
18. The method according to claim 14, wherein the additional agent comprises: a therapeutic agent (for example, an anti-cancer agent, such as a chemotherapeutic agent, e.g., chlormethine, 5-fluorouracil, camustine, ifosfamide, thiotepa, etc.); an anti-cancer agent (for example, curcumin, kaempferol, paclitaxel, resveratrol, silamarin, vincristine, etc.); an antimicrobial agent (for example, artemisinim, caffeic acid, capsaicin, coumarin, eugenol, menthol, etc.); an anti-inflammatory agent (for example, capsaicin, colchicine, curcumin, epigallocatechin-3-gallate, quercetin, resveratrol, etc.); a neuroprotective agent (for example, bacoside A, bilobalide, curcumin, galantamine, ginsenosides, withaferin A); an antioxidant agent (for example, curcumin, cyanidin, gingerol, ginkgo biloba, glycyrrhizin quercetin etc);a cardiovascular protection agent (for example, berberine, curcumin, dihydrotanshinone, quercetin, resveratrol, etc.); essential oils, metals (silver ions, copper ions), zinc oxide, graphene oxide or carbon nanotubes, photoactive compounds (titanium dioxide, benzophenone, MoS2,MnO2, zinc oxide, gold nanoparticles), eugenol, menthol, eucalyptol, capsaicin, polyphenols, etc.; a fuel agent, for example, cerium oxide+H2O2, calcium carbonate + acid, catalysts (e.g., aluminum oxide, copper oxide, silver oxide, iron oxide, cobalt oxide), etc.; or a diagnostic and / or imaging agent, for example, fluorescent molecules, iodine, barium, supramagnetic iron oxide, bismuth, gold, etc., or a combination thereof.
19. The method according to claim 1, wherein said initiating polymerization comprises introducing polymerization initiator into the reactor, and wherein the polymerization initiator is tert-butyl peroxide vapor that contacts a heated filament array to generate tert-butoxyl radicals that initiate free radical polymerization.
20. The method according to claim 19, wherein the heated filament array is at a temperature of less than or equal to 400 °C.
21. The method according to claim 1, wherein the polymer particles have a size of 0.01 nm to 1,000,000 nm.
22. The method according to claim 1, wherein, during said method, the LC is in, and remains in, a phase as a template for polymerization wherein the phase is selected from nematic phase, chiral nematic phase, smectic phase, polar smectic phase, chiral smectic phase, frustrated phase and / or discotic phase.
23. The method according to any one of the preceding claims, wherein temperatures employed during the process do not exceed 450 °C.
24. The method according to claim 1, comprising using in-situ microscopy to monitor the chain-growth polymerization.
25. A polymer particle prepared according to the method of claim 1.
Citation Information
Patent Citations
A method for preparing biodegradable polymer nanofibers by chemical vapor deposition
CN107653506B
Molecularly-imprinted material made by template-directed synthesis
US20030139483A1
Nanocomposites and methods for synthesis and use thereof
US20070205394A1
Aerosol photopolymerization
US20130079482A1
Polyamide nanoparticles and uses thereof
US20190002706A1
